Report

Raising the bar in capital markets risk management

if you’re a professional asset manager, you need top-notch risk management systems to keep tabs on exactly what’s happening at the coal-face in real-time. The big problem is that many such institutions presently have a hotch-potch of legacy systems. Haphazardly assembled over time into a mishmash of point-solutions operating in discreet silos with minimal integration. Making it almost impossible for Chief Risk Officers and/or Directors to assess a firm’s true exposure.

This is where KRM22 fits in. It is 100% focused on the Capital Markets, and is in the process of creating a ‘1st-of-its-kind’ Global Risk Platform. Not only addressing all its clients’ regulatory, market, technology and operational risk requirements, but also materially reducing their costs and complexity.

At today’s interims, the company said that it now had 37 institutional customers (vs 26 Dec’18) and delivered H1’19 turnover of £1.8m (vs £1.3m FY18). Exiting June with Annualised Recurring Revenues (ARR) of £4.1m (vs £1.0m LY & £3.3m Dec’18). Nonetheless the timings of some contracts that were anticipated to be secured over the summer, instead shifted to the right (deferred, not lost) due primarily to the less certain macro environment.

Consequently, we have reduced our FY19 ARR and sales estimates to £5.15m (from £6.67m before) and £4.2m (£5.8m) respectively - with the valuation similarly dropping from 110p to 70p/share, equivalent to circa 3x FY19 ARR. Equally though, there should be no reason why the stock can’t command (at least) a 4.0x rating; worth c. 130p/share – say by Dec’20, based on ARR of £7.25m and closing net debt of £3.96m.
Underlying
KRM22

KRM22 PLC. KRM22 plc is a United Kingdom-based closed-ended investment company. The Company's objective is creating value for its investors through the acquisition of or investment in and subsequent growth and development of target in the technology and software sector. The Company may invest or acquire globally, including emerging markets, and its short-term focus is on the United Kingdom, Europe, North America and Asia.

Provider
Equity Development
Equity Development

​Equity Development enables companies to become better understood and supported by investors. Since our launch in 1996 we have consistently focused on helping our clients improve their communication and relationships with both existing and potential shareholders. Our clients have come from a wide variety of sectors and domiciles, are both private and quoted and range in size from micro-cap to $multi-billions. We offer free access to company research notes written by experienced analysts. These notes include detailed forecasts, financial models and a fair value. We host regular Private Investor Forums at which investors have the opportunity to hear company directors present, and to ask questions. These are free to attend. We broadcast live Webinars with company management that include active Q&A. We also make the recordings available online. We arrange face to face meetings between private investors and company management. We are active users of Twitter, commenting daily on company news, share price moves, Directors’ Dealings, Equity Development Research Notes & Events.

Analysts
Paul Hill

Other Reports on these Companies
Other Reports from Equity Development

ResearchPool Subscriptions

Get the most out of your insights

Get in touch